Search results for: Value-Based Pricing

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

11 July 2023

…in terms, of jobs and value created in the economy and other sectors of dementia’s research supply chain, are positive and significant. In particular, dementia research totalled: More than 7k full-time…

Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)

1 December 2016

Published paper using MCDA to obtain preferences on decision criteria across three stakeholder groups (patients, clinicians and payers) in Italy and to assess the value of obinutuzumab for rituximab-refractory iNHL….

Measuring and Valuing Outcomes

…Seven reflections on the UK EQ-5D-5L value set – and what comes next The long-awaited UK EQ-5D-5L value set has been published, marking a key moment for health technology assessment….

Willingness to Pay and Publicly Funded Health Care: Contradiction in Terms?

1 November 2011

Because health care resources always are scarce, decisions about what (and what not) to pay for cannot be avoided. Deciding how to value health and aspects of health care continue…

Lunchtime Seminar: Capturing Preferences about Treatment at the End of Life

9 April 2013

…has been available that either supports or refutes the premise that society places special value on life-extending treatments at the end of life. Future studies of society’s preference about such…

Exploring the Link Between Health and Wealth in Government Decision Making

16 May 2013

Traditionally, decision makers both within and outside the health sector have thought of the value of health interventions primarily in terms of reduced morbidity or mortality. Health care, however, produces…

What Is the Role of Cost-Effectiveness Evidence in US Health Care?

31 July 2013

…value of expanding that. At an OHE seminar last week, Dr James Chambers of Tufts Medical School examined the role cost-effectiveness evidence plays in health care resource allocation in the…

NICE Decisions: Cost-effectiveness is the Most Significant Predictor

21 November 2013

…(NICE) undertakes appraisals of selected technologies and issues guidance intended to ensure quality and value for money. Its decisions are binding within the NHS and also affect decisions by health…

Use of Cost-effectiveness Evidence in US Health Care: Seminar Briefing

1 April 2014

Just published by OHE, this Seminar Briefing summarises remarks at an OHE Lunchtime Seminar by Dr James Chambers of the Center for the Evaluation of Value and Risk in Health…